Patent Assignment
Reel/Frame 046250/0335
Assignment of Assignor's Interest
Recorded: 2018-07-02
Pages: 3
Assignor
MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED
Executed: 2018-06-27
Assignee
HARM REDUCTION THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 400, BETHESDA, MARYLAND, 20814
Covered Properties
(2)
Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
Application:
15/418,138 →
Publication:
US 2017/0231904
Intranasal Pharmaceutical Dosage Forms Comprising Naloxone
Application:
15/590,466 →
Publication:
US 2017/0304192
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 25, 2018
From: STRANG, JOHN; OKSCHE, ALEXANDER; HARRIS, STEPHEN; SMITH, KEVIN
To: EURO-CELTIQUE S.A.
Reel/Frame 045906/0547 →
Assignment of Assignor's Interest
May 25, 2018
From: STRANG, JOHN; OKSCHE, ALEXANDER; HARRIS, STEPHEN; SMITH, KEVIN
To: EURO-CELTIQUE S.A.
Reel/Frame 045906/0682 →
Assignment of Assignor's Interest
May 25, 2018
From: EURO-CELTIQUE S.A.
To: MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED
Reel/Frame 045906/0704 →
Assignment of Assignor's Interest
May 25, 2018
From: EURO-CELTIQUE S.A.
To: MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED
Reel/Frame 045906/0720 →